ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Lifesciences | Healthcare & Wellness

ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Market by Drug Class, Application, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific dermatological therapeutics market is expected to make progress at a CAGR of 8.32% in terms of revenue throughout the estimated period 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The countries assessed in this region include:

•           China

•           Japan

•           India

•           South Korea

•           Australia & New Zealand

•           ASEAN countries

•           Rest of APAC countries

2019’s World Population Aging report estimates the elderly population of China, aged 65 years and above, to rise steeply over the coming years. In 2019, there were 164.48 million people in this age group, and this number is expected to rise to 246.98 million people by 2030. Older adults are more likely to be affected with dermatological conditions. And this is expected to raise the demand for dermatological therapeutics in the country. Moreover, other factors, such as changes in lifestyle, improvement in healthcare infrastructure, and increased public awareness regarding health risks, are leading the Chinese dermatological therapeutics market on a growth path.

Even in Japan, the geriatric population, comprising people aged 65 years and above, is continually rising. In its 2015 World Population Prospects report, the United Nations had estimated this population to amount to 35.9 million people in 2020. It must also be noted that, people in Japan are aging faster than people in any other country. The elderly require dermatological services frequently, as they are highly prone to skin-related disorders. They form a large section of the customer base for dermatological procedures, which has increased the demand for dermatological therapeutics. This increased demand is fueling the growth of the studied market in Japan over the projected period.

Galderma provides science-based solutions for skin health. The company operates through three business units: Prescription, Aesthetics, and Consumer care. Its product portfolio includes a range of leading medical and consumer skin health brands, for conditions such as rosacea, acne, atopic dermatitis, psoriasis, sun protection, skin aging, and skin cancer. Galderma has a significant presence in the Asia-Pacific.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

TABLE OF CONTENTS   

1. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   ASIA-PACIFIC IS MOST ENCOURAGING REGIONAL MARKET

2.2.2.   CHINA IS LEADING OVERALL MARKET

2.2.3.   ADVANCEMENTS IN BIOLOGICS

2.2.4.   ATOPIC DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS

2.3.5.   THREAT OF COMPETITIVE RIVALRY

2.4. IMPACT OF COVID-19 – DERMATOLOGICAL THERAPEUTICS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   INCREASING BURDEN OF DERMATOLOGICAL DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   GRAVE SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS

2.9. MARKET OPPORTUNITIES

2.9.1.   RISE IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION

2.10. MARKET CHALLENGES

2.10.1.    UNAWARENESS REGARDING DERMATOLOGICAL DIAGNOSIS

3. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS

3.1. ANTI-INFECTIVES

3.2. CORTICOSTEROIDS

3.3. ANTI-ACNE

3.4. CALCINEURIN INHIBITORS

3.5. RETINOIDS

3.6. OTHER DRUG CLASSES

4. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION

4.1. ALOPECIA

4.2. HERPES

4.3. PSORIASIS

4.4. ROSACEA

4.5. ATOPIC DERMATITIS

4.6. ACNE VULGARIS

4.7. OTHER APPLICATIONS

5. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK

5.1. ASIA-PACIFIC

5.1.1.   CHINA

5.1.2.   JAPAN

5.1.3.   INDIA

5.1.4.   SOUTH KOREA

5.1.5.   ASEAN COUNTRIES

5.1.6.   AUSTRALIA & NEW ZEALAND

5.1.7.   REST OF ASIA-PACIFIC

6. COMPETITIVE LANDSCAPE

6.1. ABBVIE INC

6.2. ALLERGAN

6.3. ALMIRALL

6.4. AMGEN INC

6.5. BAUSCH HEALTH COMPANIES INC

6.6. GALDERMA

6.7. GLAXOSMITHKLINE PLC

6.8. JOHNSON & JOHNSON

6.9. NOVARTIS AG

6.10. PFIZER INC

6.11. AGI DERMATICS

6.12. LEO PHARMA A/S

6.13. MERCK & CO

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of table

TABLE 1: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 5: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 6: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 3: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 4: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 5: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 6: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 7: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 8: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 9: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 10: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 11: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 12: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN $ BILLION)

FIGURE 13: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 14: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 15: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 16: CHINA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 17: JAPAN DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 18: INDIA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 19: SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 20: ASEAN COUNTRIES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 21: AUSTRALIA & NEW ZEALAND DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 22: REST OF ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;